529 related articles for article (PubMed ID: 10972087)
1. VEINCTR-N, an immunogenic epitope of Fas (CD95/Apo-I), and soluble Fas enhance T-cell apoptosis in vitro. II. Functional analysis and possible implications in HIV-1 disease.
Silvestris F; Cafforio P; Tucci M; Del Prete A; Dammacco F
Mol Med; 2000 Jun; 6(6):509-26. PubMed ID: 10972087
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of an eight amino acid domain shared by Fas (CD95/Apo-I) and HIV-1 gp120. I. Structural and antigenic analysis.
Silvestris F; Cocco T; Cafforio P; Calvani N; Dammacco F
Mol Med; 2000 Jun; 6(6):494-508. PubMed ID: 10972086
[TBL] [Abstract][Full Text] [Related]
3. Anti-Fas (CD95/Apo-I) autoantibodies and soluble Fas levels concur in T cell depletion in HIV type 1 infection.
Silvestris F; Grinello D; Del Prete A; Cafforio P; Quarto M; Dammacco F
AIDS Res Hum Retroviruses; 2001 May; 17(7):603-14. PubMed ID: 11375056
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking of Fas by antibodies to a peculiar domain of gp120 V3 loop can enhance T cell apoptosis in HIV-1-infected patients.
Silvestris F; Nagata S; Cafforio P; Silvestris N; Dammacco F
J Exp Med; 1996 Dec; 184(6):2287-300. PubMed ID: 8976184
[TBL] [Abstract][Full Text] [Related]
5. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists.
Estaquier J; Tanaka M; Suda T; Nagata S; Golstein P; Ameisen JC
Blood; 1996 Jun; 87(12):4959-66. PubMed ID: 8652808
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis.
Silvestris F; Cafforio P; Frassanito MA; Tucci M; Romito A; Nagata S; Dammacco F
AIDS; 1996 Feb; 10(2):131-41. PubMed ID: 8838700
[TBL] [Abstract][Full Text] [Related]
7. Functional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopenia.
Silvestris F; Cafforio P; Camarda G; Tucci M; Frassanito MA; Dammacco F
Int J Clin Lab Res; 1998; 28(4):215-25. PubMed ID: 9879494
[TBL] [Abstract][Full Text] [Related]
8. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
9. Serum elevations of soluble Fas (CD95/apo-I) concur in deregulating T cell apoptosis during active lupus disease.
Silvestris F; Williams RC; Calvani N; Grinello D; Tucci M; Cafforio P; Dammacco F
Clin Exp Med; 2002 May; 2(1):13-27. PubMed ID: 12049185
[TBL] [Abstract][Full Text] [Related]
10. Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels.
Bruserud O; Ulvestad E
Cancer Immunol Immunother; 2000 Sep; 49(7):377-87. PubMed ID: 10999464
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR.
Pinti M; Nasi M; Moretti L; Mussini C; Petrusca D; Esposito R; Cossarizza A
Ann N Y Acad Sci; 2000; 926():46-51. PubMed ID: 11193040
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid.
Mitra D; Steiner M; Lynch DH; Staiano-Coico L; Laurence J
Immunology; 1996 Apr; 87(4):581-5. PubMed ID: 8675212
[TBL] [Abstract][Full Text] [Related]
13. Regulation of T-cell apoptosis: a mixed lymphocyte reaction model.
O'Flaherty E; Wong WK; Pettit SJ; Seymour K; Ali S; Kirby JA
Immunology; 2000 Jul; 100(3):289-99. PubMed ID: 10929050
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection.
Cossarizza A; Stent G; Mussini C; Paganelli R; Borghi V; Nuzzo C; Pinti M; Pedrazzi J; Benatti F; Esposito R; Røsok B; Nagata S; Vella S; Franceschi C; De Rienzo B
AIDS; 2000 Mar; 14(4):345-55. PubMed ID: 10770536
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection.
Katsikis PD; Garcia-Ojeda ME; Torres-Roca JF; Tijoe IM; Smith CA; Herzenberg LA; Herzenberg LA
J Exp Med; 1997 Oct; 186(8):1365-72. PubMed ID: 9334376
[TBL] [Abstract][Full Text] [Related]
16. Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells.
Arokium H; Kamata M; Chen I
J Virol; 2009 Nov; 83(21):11283-97. PubMed ID: 19692467
[TBL] [Abstract][Full Text] [Related]
17. Mapping of the linear site on the Fas/APO-1 molecule targeted by the prototypic anti-Fas mAb.
Fadeel B; Thorpe J; Chiodi F
Int Immunol; 1995 Dec; 7(12):1967-75. PubMed ID: 8746566
[TBL] [Abstract][Full Text] [Related]
18. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals.
Katsikis PD; Wunderlich ES; Smith CA; Herzenberg LA; Herzenberg LA
J Exp Med; 1995 Jun; 181(6):2029-36. PubMed ID: 7539037
[TBL] [Abstract][Full Text] [Related]
19. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
20. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells.
Martínez-Lorenzo MJ; Alava MA; Gamen S; Kim KJ; Chuntharapai A; Piñeiro A; Naval J; Anel A
Eur J Immunol; 1998 Sep; 28(9):2714-25. PubMed ID: 9754559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
